News Clovis PARP drug gets fast US review in new ovarian cancer u... Impressed by survival data, FDA hastens review in expanded patient group
Partner Content Partner Content Exscientia to discuss role of AI in small molecule drug disc... AI in small molecule drug discovery
News Researchers start trial on AZ WEE1 drug in head and neck can... Phase 1 trial investigates use before and after surgery
News Tesaro gets European approval on Zejula, set to challenge AZ Tesaro's PARP drug approved in wider ovarian cancer population
Partner Content Partner Content Abbvie and Astrazeneca to present keynote address’ at SMi’s ... Drug Discovery conference 2018
News FDA approves Mirum's oral drug for rare disease FOP Mirum's new oral therapy for rare bone disease fibrodysplasia ossificans progressiva (FOP) looks set to challenge Regeneron's intravenous Pasatru.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
